Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
Bockorny, Bruno, Andrea J Bullock, Thomas A Abrams, Salomao Faintuch, David C Alsop, Nahum Goldberg, Muneeb Ahmed, and Rebecca A Miksad. 2022. “Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.”. Digestive Diseases and Sciences 67 (7): 3455-63.